The full TRIUMPH program spans eight Phase 3 trials plus TRIUMPH-CVOT, enrolling more than 5,800 participants in the core weight-management trials and roughly 10,000 in the cardiovascular outcomes trial
Strand Bio does not provide dosing, administration, treatment, or diagnostic guidance
Avoid use during pregnancy, cancer, or without medical supervision
By using the Website, User represents and warrants that User is at least 18 years of age and has the legal capacity to enter into this Agreement
Molecular Identity of AOD9604 AOD9604 is commonly described as a synthetic 16-amino-acid peptide comprising an N-terminal tyrosine linked to the human growth hormone 177191 region
It fades over weeks of rotation away from the affected site